| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Clinical Studies |
Medical Department I, Division of Endocrinology, Center of Internal Medicine (H.D., H.R., J.B., J.H., K.H.U., K.B.), and the Department of Pediatrics, Klinikum of the J. W. Goethe University (J.H.), Frankfurt/Main; and the Medical Clinic, Endocrine Department, University Hospital Benjamin Franklin, Free University of Berlin (R.F.), Berlin, Germany; and the Division of Endocrinology and Metabolism and Head and Neck Oncology Program of Mount Sinai Hospital, University of Toronto Medical School, Samuel Lunenfeld Research Institute of Mount Sinai Hospital (P.G.W.), Toronto, Ontario, Canada M5G 1X5
Address all correspondence and requests for reprints to: PD Dr. K. Badenhoop, Medizinische Klinik I, Klinikum der J. W. Goethe University, Theodor-Stern-Kai 7, D-60590 Frankfurt/Main, Germany.
The genetic susceptibility to Graves disease and type 1 (insulin-dependent) diabetes mellitus is conferred by genes in the human leukocyte antigen region on the short arm of chromosome 6, but several other genes are presumed to determine disease susceptibility. Among those candidate genes is the cytotoxic T lymphocyte antigen 4 (CTLA4) located on chromosome 2q33 in man. We investigated the distribution of the CTLA4 exon 1 polymorphism (49 A/G) in Graves disease and IDDM. This dimorphism at codon 17 results in an amino acid exchange (Thr/Ala) in the leader peptide of the expressed protein and was analyzed by PCR, single strand conformation polymorphism, and restriction fragment length polymorphism analysis in 305 patients with Graves disease, 293 patients with IDDM, and 325 controls. Patients with Graves disease had significantly more Ala alleles than controls, both as homozygotes (21% vs. 13%) and as heterozygotes (53% vs. 46%), and less Thr as homozygotes (26% vs. 42%; P < 2 x 10-4). The phenotypic frequency of Ala-positive patients (73%) was significantly higher than of controls (58%; P = 10-4; relative risk = 2). Patients with IDDM also had significantly more Ala alleles as homozygotes (19%) or heterozygotes (50%; P = 0.01). In conclusion, an alanine at codon 17 of CTLA4 is associated with genetic susceptibility to Graves disease as well as to IDDM.
This article has been cited by other articles:
![]() |
R. Simone, R. Brizzolara, A. Chiappori, F. Milintenda-Floriani, C. Natale, L. Greco, M. Schiavo, M. Bagnasco, G. Pesce, and D. Saverino A functional soluble form of CTLA-4 is present in the serum of celiac patients and correlates with mucosal injury Int. Immunol., September 1, 2009; 21(9): 1037 - 1045. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Huber, F. Menconi, S. Corathers, E. M. Jacobson, and Y. Tomer Joint Genetic Susceptibility to Type 1 Diabetes and Autoimmune Thyroiditis: from Epidemiology to Mechanisms Endocr. Rev., October 1, 2008; 29(6): 697 - 725. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ban, D. A. Greenberg, T. F. Davies, E. Jacobson, E. Concepcion, and Y. Tomer 'Linkage Analysis of Thyroid Antibody Production: Evidence for Shared Susceptibility to Clinical Autoimmune Thyroid Disease J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3589 - 3596. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-C. Chang, Y.-T. Chang, Y.-W. Tien, P.-C. Liang, I-S. Jan, S.-C. Wei, and J.-M. Wong T-Cell Regulatory Gene CTLA-4 Polymorphism/Haplotype Association with Autoimmune Pancreatitis Clin. Chem., September 1, 2007; 53(9): 1700 - 1705. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. K. Kavvoura, T. Akamizu, T. Awata, Y. Ban, D. A. Chistiakov, I. Frydecka, A. Ghaderi, S. C. Gough, Y. Hiromatsu, R. Ploski, et al. Cytotoxic T-Lymphocyte Associated Antigen 4 Gene Polymorphisms and Autoimmune Thyroid Disease: A Meta-Analysis J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3162 - 3170. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Perez-Garcia, R. De la Camara, J. Roman-Gomez, A. Jimenez-Velasco, M. Encuentra, J. B. Nieto, J. de la Rubia, A. Urbano-Ispizua, S. Brunet, A. Iriondo, et al. CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donors. Blood, July 1, 2007; 110(1): 461 - 467. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-H. Su, T.-Y. Chang, Y.-J. Lee, C.-K. Chen, H.-F. Liu, C.-C. Chu, M. Lin, P.-T. Wang, W.-C. Huang, T.-C. Chen, et al. CTLA-4 gene and susceptibility to human papillomavirus-16-associated cervical squamous cell carcinoma in Taiwanese women Carcinogenesis, June 1, 2007; 28(6): 1237 - 1240. [Abstract] [Full Text] [PDF] |
||||
![]() |
O Tapirdamaz, V Pravica, H J Metselaar, B Hansen, L Moons, J B J van Meurs, I V Hutchinson, J Shaw, K Agarwal, D H Adams, et al. Polymorphisms in the T cell regulatory gene cytotoxic T lymphocyte antigen 4 influence the rate of acute rejection after liver transplantation Gut, June 1, 2006; 55(6): 863 - 868. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kahles, E. Ramos-Lopez, B. Lange, O. Zwermann, M. Reincke, and K. Badenhoop Sex-specific association of PTPN22 1858T with type 1 diabetes but not with Hashimoto's thyroiditis or Addison's disease in the German population Eur. J. Endocrinol., December 1, 2005; 153(6): 895 - 899. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Steck, T. L. Bugawan, A. M. Valdes, L. M. Emery, A. Blair, J. M. Norris, M. J. Redondo, S. R. Babu, H. A. Erlich, G. S. Eisenbarth, et al. Association of Non-HLA Genes With Type 1 Diabetes Autoimmunity Diabetes, August 1, 2005; 54(8): 2482 - 2486. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. K. Kavvoura and J. P. A. Ioannidis CTLA-4 Gene Polymorphisms and Susceptibility to Type 1 Diabetes Mellitus: A HuGE Review and Meta-Analysis Am. J. Epidemiol., July 1, 2005; 162(1): 3 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lindley, C. M. Dayan, A. Bishop, B. O. Roep, M. Peakman, and T. I.M. Tree Defective Suppressor Function in CD4+CD25+ T-Cells From Patients With Type 1 Diabetes Diabetes, January 1, 2005; 54(1): 92 - 99. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ban, E. S. Concepcion, R. Villanueva, D. A. Greenberg, T. F. Davies, and Y. Tomer Analysis of Immune Regulatory Genes in Familial and Sporadic Graves' Disease J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4562 - 4568. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-W. Wang, R.-T. Liu, S.-H. H. Juo, S.-T. Wang, Y.-H. Hu, C.-J. Hsieh, M.-H. Chen, I-Y. Chen, and C.-L. Wu Cytotoxic T Lymphocyte-Associated Molecule-4 Polymorphism and Relapse of Graves' Hyperthyroidism after Antithyroid Withdrawal J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 169 - 173. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Hirashima, T Fukazawa, K Abe, Y Morita, M Kusaoi, and H Hashimoto Expression and activity analyses of CTLA4 in peripheral blood lymphocytes in systemic lupus erythematosus patients Lupus, January 1, 2004; 13(1): 24 - 31. [Abstract] [PDF] |
||||
![]() |
B. S. Prabhakar, R. S. Bahn, and T. J. Smith Current Perspective on the Pathogenesis of Graves' Disease and Ophthalmopathy Endocr. Rev., December 1, 2003; 24(6): 802 - 835. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tomer and T. F. Davies Searching for the Autoimmune Thyroid Disease Susceptibility Genes: From Gene Mapping to Gene Function Endocr. Rev., October 1, 2003; 24(5): 694 - 717. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mochizuki, S. Amemiya, K. Kobayashi, K. Kobayashi, Y. Shimura, T. Ishihara, Y. Nakagomi, K. Onigata, S. Tamai, A. Kasuga, et al. Association of the CTLA-4 Gene 49 A/G Polymorphism With Type 1 Diabetes and Autoimmune Thyroid Disease in Japanese Children Diabetes Care, March 1, 2003; 26(3): 843 - 847. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Vaidya, P. Kendall-Taylor, and S. H. S. Pearce The Genetics of Autoimmune Thyroid Disease J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5385 - 5397. [Full Text] [PDF] |
||||
![]() |
S. Anjos, A. Nguyen, H. Ounissi-Benkalha, M.-C. Tessier, and C. Polychronakos A Common Autoimmunity Predisposing Signal Peptide Variant of the Cytotoxic T-lymphocyte Antigen 4 Results in Inefficient Glycosylation of the Susceptibility Allele J. Biol. Chem., November 22, 2002; 277(48): 46478 - 46486. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Y. Lee, Y. H. Lee, C. Shin, J. J. Shim, K. H. Kang, S. H. Yoo, and K. H. In Association of Asthma Severity and Bronchial Hyperresponsiveness With a Polymorphism in the Cytotoxic T-Lymphocyte Antigen-4 Gene* Chest, July 1, 2002; 122(1): 171 - 176. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Betterle, C. Dal Pra, F. Mantero, and R. Zanchetta Autoimmune Adrenal Insufficiency and Autoimmune Polyendocrine Syndromes: Autoantibodies, Autoantigens, and Their Applicability in Diagnosis and Disease Prediction Endocr. Rev., June 1, 2002; 23(3): 327 - 364. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kinjo, N. Takasu, I. Komiya, T. Tomoyose, M. Takara, T. Kouki, Y. Shimajiri, K. Yabiku, and H. Yoshimura Remission of Graves' Hyperthyroidism and A/G Polymorphism at Position 49 in Exon 1 of Cytotoxic T Lymphocyte-Associated Molecule-4 Gene J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2593 - 2596. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Osei-Hyiaman, L. Hou, R. Zhiyin, Z. Zhiming, H. Yu, A. A. Amankwah, and S. Harada Association of a Novel Point Mutation (C159G) of the CTLA4 Gene With Type 1 Diabetes in West Africans but not in Chinese Diabetes, September 1, 2001; 50(9): 2169 - 2171. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Holopainen and J. A. Partanen Technical Note: Linkage Disequilibrium and Disease-Associated CTLA4 Gene Polymorphisms J. Immunol., September 1, 2001; 167(5): 2457 - 2458. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sakai, S. Shirasawa, N. Ishikawa, K. Ito, H. Tamai, K. Kuma, T. Akamizu, M. Tanimura, K. Furugaki, K. Yamamoto, et al. Identification of susceptibility loci for autoimmune thyroid disease to 5q31-q33 and Hashimoto's thyroiditis to 8q23-q24 by multipoint affected sib-pair linkage analysis in Japanese Hum. Mol. Genet., June 1, 2001; 10(13): 1379 - 1386. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ahmed, K. Ihara, S. Kanemitsu, H. Nakashima, T. Otsuka, K. Tsuzaka, T. Takeuchi, and T. Hara Association of CTLA-4 but not CD28 gene polymorphisms with systemic lupus erythematosus in the Japanese population Rheumatology, June 1, 2001; 40(6): 662 - 667. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Metcalfe, G. A. Hitman, R. E. Rowe, M. Hawa, X. Huang, T. Stewart, and R. D. G. Leslie Concordance for Type 1 Diabetes in Identical Twins Is Affected by Insulin Genotype Diabetes Care, May 1, 2001; 24(5): 838 - 842. [Abstract] [Full Text] |
||||
![]() |
Y. Tomer, D. A. Greenberg, G. Barbesino, E. Concepcion, and T. F. Davies CTLA-4 and Not CD28 Is a Susceptibility Gene for Thyroid Autoantibody Production J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1687 - 1693. [Abstract] [Full Text] |
||||
![]() |
H. Imrie, B. Vaidya, P. Perros, W. F. Kelly, A. D. Toft, E. T. Young, P. Kendall-Taylor, and S. H. S. Pearce Evidence for a Graves' Disease Susceptibility Locus at Chromosome Xp11 in a United Kingdom Population J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 626 - 630. [Abstract] [Full Text] |
||||
![]() |
H. Rau, J. Braun, H. Donner, J. Seissler, T. Siegmund, K. H. Usadel, and K. Badenhoop The Codon 17 Polymorphism of the CTLA4 Gene in Type 2 Diabetes Mellitus J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 653 - 655. [Abstract] [Full Text] |
||||
![]() |
Y. Ban, M. Taniyama, and Y. Ban Vitamin D Receptor Gene Polymorphism Is Associated with Graves' Disease in the Japanese Population J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4639 - 4643. [Abstract] [Full Text] |
||||
![]() |
T. Kouki, Y. Sawai, C. A. Gardine, M.-E. Fisfalen, M.-L. Alegre, and L. J. DeGroot CTLA-4 Gene Polymorphism at Position 49 in Exon 1 Reduces the Inhibitory Function of CTLA-4 and Contributes to the Pathogenesis of Graves' Disease J. Immunol., December 1, 2000; 165(11): 6606 - 6611. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Oaks and K. M. Hallett Cutting Edge: A Soluble Form of CTLA-4 in Patients with Autoimmune Thyroid Disease J. Immunol., May 15, 2000; 164(10): 5015 - 5018. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q.-Y. Chen, D. Nadell, X.-Y. Zhang, A. Kukreja, Y.-J. Huang, J. Wise, F. Svec, R. Richards, K. E. Friday, A. Vargas, et al. The Human Leukocyte Antigen HLA DRB3*0202/DQA1*0501 Haplotype Is Associated with Graves' Disease in African Americans J. Clin. Endocrinol. Metab., April 1, 2000; 85(4): 1545 - 1549. [Abstract] [Full Text] |
||||
![]() |
R. Nithiyananthan, J. M. Heward, A. Allahabadia, A. H. Barnett, J. A. Franklyn, and S. C. L. Gough A Heterozygous Deletion of the Autoimmune Regulator (AIRE1) Gene, Autoimmune Thyroid Disease, and Type 1 Diabetes: No Evidence for Association J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1320 - 1322. [Abstract] [Full Text] |
||||
![]() |
B. Vaidya, H. Imrie, D. R. Geatch, P. Perros, S. G. Ball, P. H. Baylis, D. Carr, S. J. Hurel, R. A. James, W. F. Kelly, et al. Association Analysis of the Cytotoxic T Lymphocyte Antigen-4 (CTLA-4) and Autoimmune Regulator-1 (AIRE-1) Genes in Sporadic Autoimmune Addison's Disease J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 688 - 691. [Abstract] [Full Text] |
||||
![]() |
A. Barton, A. Myerscough, S. John, M. Gonzalez-Gay, W. Ollier, and J. Worthington A single nucleotide polymorphism in exon 1 of cytotoxic T-lymphocyte-associated-4 (CTLA-4) is not associated with rheumatoid arthritis Rheumatology, January 1, 2000; 39(1): 63 - 66. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Gambelunghe, A. Falorni, M. Ghaderi, S. Laureti, C. Tortoioli, F. Santeusanio, P. Brunetti, and C. B. Sanjeevi Microsatellite Polymorphism of the MHC Class I Chain-Related (MIC-A and MIC-B) Genes Marks the Risk for Autoimmune Addison's Disease J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3701 - 3707. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Barrat, F. Le Deist, M. Benkerrou, P. Bousso, J. Feldmann, A. Fischer, and G. de Saint Basile Defective CTLA-4 cycling pathway in Chediak-Higashi syndrome: A possible mechanism for deregulation of T lymphocyte activation PNAS, July 20, 1999; 96(15): 8645 - 8650. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Vaidya, H. Imrie, P. Perros, E. T. Young, W. F. Kelly, D. Carr, D. M. Large, A. D. Toft, M. I. McCarthy, P. Kendall-Taylor, et al. The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus Hum. Mol. Genet., July 1, 1999; 8(7): 1195 - 1199. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Heward, A. Allahabadia, M. Armitage, A. Hattersley, P. M. Dodson, K. Macleod, J. Carr-Smith, J. Daykin, A. Daly, M. C. Sheppard, et al. The Development of Graves' Disease and the CTLA-4 Gene on Chromosome 2q33 J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2398 - 2401. [Abstract] [Full Text] |
||||
![]() |
T. Matsui, M. Kurokawa, T. Kobata, S. Oki, M. Azuma, S. Tohma, T. Inoue, K. Yamamoto, K. Nishioka, and T. Kato Autoantibodies to T Cell Costimulatory Molecules in Systemic Autoimmune Diseases J. Immunol., April 1, 1999; 162(7): 4328 - 4335. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kalmann and M. P. Mourits Diabetes mellitus: a risk factor in patients with Graves' orbitopathy Br J Ophthalmol, April 1, 1999; 83(4): 463 - 465. [Abstract] [Full Text] |
||||
![]() |
J. Heward, C. Gordon, A. Allahabadia, A. H Barnett, J. A Franklyn, and S. C L Gough The A-G polymorphism in exon 1 of the CTLA-4 gene is not associated with systemic lupus erythematosus Ann Rheum Dis, March 1, 1999; 58(3): 193 - 195. [Abstract] [Full Text] |
||||
![]() |
K.A. Kaufman, J.A. Bowen, A.F. Tsai, J.A. Bluestone, J.S. Hunt, and C. Ober The CTLA-4 gene is expressed in placental fibroblasts Mol. Hum. Reprod., January 1, 1999; 5(1): 84 - 87. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Cilio, M. R. Daws, A. Malashicheva, C. L. Sentman, and D. Holmberg Cytotoxic T Lymphocyte Antigen 4 Is Induced in the Thymus upon In Vivo Activation and Its Blockade Prevents Anti-CD3-mediated Depletion of Thymocytes J. Exp. Med., October 5, 1998; 188(7): 1239 - 1246. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Heward, A. Allahabadia, J. Daykin, J. Carr-Smith, A. Daly, M. Armitage, P. M. Dodson, M. C. Sheppard, A. H. Barnett, J. A. Franklyn, et al. Linkage Disequilibrium between the Human Leukocyte Antigen Class II Region of the Major Histocompatibility Complex and Graves' Disease: Replication Using a Population Case Control and Family-Based Study J. Clin. Endocrinol. Metab., October 1, 1998; 83(10): 3394 - 3397. [Abstract] [Full Text] |
||||
![]() |
I Djilali-Saiah, J Schmitz, E Harfouch-Hammoud, J-F Mougenot, J-F Bach, and S Caillat-Zucman CTLA-4 gene polymorphism is associated with predisposition to coeliac disease Gut, August 1, 1998; 43(2): 187 - 189. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Barbesino, Y. Tomer, E. Concepcion, T. F. Davies, and D. A. Greenberg the International Consortium Linkage Analysis of Candidate Genes in Autoimmune Thyroid Disease: 1. Selected Immunoregulatory Genes J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1580 - 1584. [Abstract] [Full Text] |
||||
![]() |
J. R. Baker Jr Autoimmune Endocrine Disease JAMA, December 10, 1997; 278(22): 1931 - 1937. [Abstract] [PDF] |
||||
![]() |
H. Donner, J. Braun, C. Seidl, H. Rau, R. Finke, M. Ventz, P. G. Walfish, K. H. Usadel, and K. Badenhoop Codon 17 Polymorphism of the Cytotoxic T Lymphocyte Antigen 4 Gene in Hashimoto's Thyroiditis and Addison's Disease J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 4130 - 4132. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |